MonoMac-1 cells expressing CD16 and CD163
US11846629B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2017 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Jul 24, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides monocytes expressing CD16 and CD163 and experimental system for drug screening or evaluating drug candidates where the modulation of CD16 and CD163 is desired.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.